Home LiteratureArticle Details
PMID: 17923506 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells.

The Journal of experimental medicine ·Vol. 204 ·No. 11 ·2007-10-29 ·Pages 2579-90

Caminschi I, Ahmet F, Heger K, Brady J, Nutt SL, Vremec D, Pietersz S, Lahoud MH, Schofield L, Hansen DS, O'Keeffe M, Smyth MJ, Bedoui S, Davey GM, Villadangos JA, Heath WR, Shortman K

Abstract

Interferon-producing killer dendritic cells (IKDCs) have been described as possessing the lytic potential of NK cells and the antigen-presenting capacity of dendritic cells (DCs). In this study, we examine the lytic function and antigen-presenting capacity of mouse spleen IKDCs, including those found in DC preparations. IKDCs efficiently killed NK cell targets, without requiring additional activation stimuli. However, in our hands, when exposed to protein antigen or to MHC class II peptide, IKDCs induced little or no T cell proliferation relative to conventional DCs or plasmacytoid DCs, either before or after activation with CpG, or in several disease models. Certain developmental features indicated that IKDCs resembled NK cells more than DCs. IKDCs, like NK cells, did not express the transcription factor PU.1 and were absent from recombinase activating gene-2-null, common gamma-chain-null (Rag2(-/-)Il2rg(-/-)) mice. When cultured with IL-15 and -18, IKDCs proliferated extensively, like NK cells. Under these conditions, a proportion of expanded IKDCs and NK cells expressed high levels of surface MHC class II. However, even such MHC class II(+) IKDCs and NK cells induced poor T cell proliferative responses compared with DCs. Thus, IKDCs resemble NK cells functionally, and neither cell type could be induced to be effective antigen-presenting cells.

MeSH Terms
Animals Dendritic Cells/classification,immunology Histocompatibility Antigens Class II/immunology Immunophenotyping Integrin alpha2/analysis,immunology Interferons/biosynthesis,immunology Killer Cells, Natural/classification,immunology Leukocyte Common Antigens/analysis,immunology Lymphocyte Activation Mice Spleen/immunology T-Lymphocytes/immunology
Chemicals
Histocompatibility Antigens Class II Integrin alpha2 Interferons Leukocyte Common Antigens
Authors & Affiliations
17 authors, click to expand affiliations / ORCID
Caminschi Irina
Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, 3050, Australia. caminschi@wehi.edu.au
Ahmet Fatma
Heger Klaus
Brady Jason
Nutt Stephen L
Vremec David
Pietersz Suzanne
Lahoud Mireille H
Schofield Louis
Hansen Diana S
O'Keeffe Meredith
Smyth Mark J
Bedoui Sammy
Davey Gayle M
Villadangos Jose A
Heath William R
Shortman Ken
References (36)
36 references, click to expand
  1. Dendritic cell precursor populations of mouse blood: identification of the murine homologues of human blood plasmacytoid pre-DC2 and CD11c+ DC1 precursors.
    Blood. 2003 Feb 15;101(4):1453-9 PMID: 12393665
  2. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity.
    Nat Immunol. 2006 Feb;7(2):165-72 PMID: 16415871
  3. Life cycle, migration and antigen presenting functions of spleen and lymph node dendritic cells: limitations of the Langerhans cells paradigm.
    Semin Immunol. 2005 Aug;17(4):262-72 PMID: 15946854
  4. Priming of CTLs by lymphocytic choriomeningitis virus depends on dendritic cells.
    J Immunol. 2005 Apr 1;174(7):3920-4 PMID: 15778347
  5. CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen.
    J Immunol. 2000 Mar 15;164(6):2978-86 PMID: 10706685
  6. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells.
    Blood. 2007 Feb 1;109(3):1165-73 PMID: 17038535
  7. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation.
    J Immunol. 1999 Mar 1;162(5):2761-5 PMID: 10072522
  8. Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis?
    Trends Immunol. 2007 Mar;28(3):108-14 PMID: 17267285
  9. Novel APC-like properties of human NK cells directly regulate T cell activation.
    J Clin Invest. 2004 Dec;114(11):1612-23 PMID: 15578093
  10. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity.
    Nat Med. 2006 Feb;12(2):207-13 PMID: 16444266
  11. Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells.
    J Exp Med. 2007 Jun 11;204(6):1441-51 PMID: 17535975
  12. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens.
    Immunity. 2002 Aug;17(2):211-20 PMID: 12196292
  13. The dendritic cell system and its role in immunogenicity.
    Annu Rev Immunol. 1991;9:271-96 PMID: 1910679
  14. CD40L blockade prevents autoimmune diabetes by induction of bitypic NK/DC regulatory cells.
    Immunity. 2002 Mar;16(3):403-15 PMID: 11911825
  15. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity.
    J Immunol. 2005 Apr 1;174(7):4127-34 PMID: 15778372
  16. Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors.
    J Exp Med. 2005 Jan 17;201(2):221-31 PMID: 15657291
  17. A subset of cytolytic dendritic cells in rat.
    J Immunol. 2000 Oct 15;165(8):4202-8 PMID: 11035052
  18. Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization.
    Int Immunol. 1997 Dec;9(12):1897-906 PMID: 9466317
  19. Immature CD4- CD103+ rat dendritic cells induce rapid caspase-independent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims.
    J Immunol. 2005 Aug 15;175(4):2408-17 PMID: 16081812
  20. Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.
    Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14943-8 PMID: 10611317
  21. Intrinsic lymphotoxin-beta receptor requirement for homeostasis of lymphoid tissue dendritic cells.
    Immunity. 2005 Apr;22(4):439-50 PMID: 15845449
  22. Natural killer or dendritic: what's in a name?
    Immunity. 2007 Jan;26(1):11-6 PMID: 17241957
  23. Mouse plasmacytoid cells: long-lived cells, heterogeneous in surface phenotype and function, that differentiate into CD8(+) dendritic cells only after microbial stimulus.
    J Exp Med. 2002 Nov 18;196(10):1307-19 PMID: 12438422
  24. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions.
    J Immunol. 2004 Sep 15;173(6):3716-24 PMID: 15356117
  25. Natural killer dendritic cells have both antigen presenting and lytic function and in response to CpG produce IFN-gamma via autocrine IL-12.
    J Immunol. 2005 Mar 1;174(5):2612-8 PMID: 15728467
  26. Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism.
    J Exp Med. 1997 Aug 4;186(3):467-72 PMID: 9236200
  27. Interferon-producing killer dendritic cells (IKDCs) arise via a unique differentiation pathway from primitive c-kitHiCD62L+ lymphoid progenitors.
    Blood. 2007 Jun 1;109(11):4825-931 PMID: 17317852
  28. Cutting edge: generation of splenic CD8+ and CD8- dendritic cell equivalents in Fms-like tyrosine kinase 3 ligand bone marrow cultures.
    J Immunol. 2005 Jun 1;174(11):6592-7 PMID: 15905497
  29. Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    J Exp Med. 1999 Oct 18;190(8):1155-64 PMID: 10523613
  30. Combined stimulation with interleukin-18 and CpG induces murine natural killer dendritic cells to produce IFN-gamma and inhibit tumor growth.
    Cancer Res. 2006 Nov 1;66(21):10497-504 PMID: 17079471
  31. A novel dendritic cell subset involved in tumor immunosurveillance.
    Nat Med. 2006 Feb;12(2):214-9 PMID: 16444265
  32. Steady-state and inflammatory dendritic-cell development.
    Nat Rev Immunol. 2007 Jan;7(1):19-30 PMID: 17170756
  33. Dendritic cells in a mature age.
    Nat Rev Immunol. 2006 Jun;6(6):476-83 PMID: 16691244
  34. Functional comparison of mouse CIRE/mouse DC-SIGN and human DC-SIGN.
    Int Immunol. 2006 May;18(5):741-53 PMID: 16569675
  35. Natural killer cell clones can efficiently process and present protein antigens.
    J Immunol. 1991 Aug 1;147(3):781-7 PMID: 1861074
  36. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    J Immunol. 2002 Nov 15;169(10):5377-81 PMID: 12421908
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
1540-9538
Published
2007-10-29
Epub
2007-00-08
Pages
2579-90
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118479
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com